Baron Small Cap Fund (BSCFX)

Portfolio Management

CliffGreenberg
Cliff Greenberg

Fund Manager since 1997

View All Commentary by Cliff

Fund Description

Baron Small Cap Fund invests primarily in small growth companies.

    

    

Portfolio Commentary

Retail Performance

Review and Outlook (for quarter ended 6/30/2016)

The market trended higher for most of the quarter as fear of a slump in global growth abated. Oil held to around $50 a barrel, stabilizing international economies. The U.S. economy chugged along, with statistics supporting 2% domestic growth. A surprisingly weak employment report for May stirred worries about the health of the seven-year expansion. However, it backed off expectations for a Federal Reserve rate increase, which the market favored. At the end of the quarter the market suffered a sudden drop when British citizens voted to leave the European Union.

The market has acted more normal this year, meaning stocks have broadly reacted to earnings results, news flows and valuation considerations, as opposed to momentum, sector rotation/factors and speculation. Our best performing stocks were companies who announced strong results and incrementally positive outlooks.

The U.S. and global economies have proven to be resilient, though we are not sure what will come of Brexit. Leading indicators in the U.S. have improved; and risk, measured by credit spreads and financial conditions, has moderated.

A good portion of our holdings are seeing growth accelerate; are growing earnings by double digits organically; and are increasing shareholder value through acquisitions, debt paydown, and/or share buy backs. After an exceptionally strong 2013, Baron Small Cap Fund has been marking time, but our holdings have been constantly growing their earnings and value. We believe valuations, which were high in retrospect, are now reasonable and are either stable or rising, especially for the visible and consistent growth that our “high quality” holdings are providing.

We believe a market environment that is so skittish is good for stocks. The Fund’s strong second quarter performance underscores just how hard it is to time when we will make our returns, which often come when least expected. It also highlights the futility of trying to predict the unpredictable and the virtue of ignoring the noise and focusing on business fundamentals. Our goal is to build and invest in a winning portfolio and “be in it to win it.”

We continue to focus on investing in a diversified portfolio of what we consider to be well-managed special growth businesses that can continue to compound growth at high rates for an extended period. This is what we have always done. We are heartened by the fact that our approach is coming back into favor after what we believe was an abnormal period where momentum, volatility, and high-multiple stocks outperformed.

Top Contributors/Detractors to Performance

Contributors (for quarter ended 6/30/2016)
  • Shares of aircraft parts manufacturer TransDigm Group, Inc. increased in Q2. The company repurchased $100 million pursuant to a $450 million share repurchase program. Transdigm continued to make accretive acquisitions, completing a significant $1 billion deal in the second quarter. We are confident that Transdigm’s management team will continue to execute on its plan to grow cash flow.

  • Shares of Press Ganey Holdings, Inc. rose in Q2 on strong revenue growth and margin expansion. Press Ganey provides patient experience and employee engagement measurement, analytics, and strategic advisory solutions for health care organizations. Growth of more than 13% in the core patient experience business was propelled by share gains and adoption of electronic surveys. We believe core growth will potentially be supplemented by new solutions such as Transparency, PROMs, and quality measures, as well as acquisitions.

  • Shares of veterinary diagnostics leader IDEXX Laboratories, Inc. rallied in Q2 on strong financial results and multiple expansion. Competitive trends are strong and improving, highlighted by instrument placement growth of almost 25%, domestic lab growth more than twice that of its main competitor, rising sales productivity, and stability in rapid assays. We think that IDEXX’s direct go-to-market model coupled with meaningful R&D-driven product enhancements will boost revenue and earnings growth over time.

Detractors (for quarter ended 6/30/2016)
  • Shares of The Chefs' Warehouse, Inc., the leading foodservice distributor to high-end, independent restaurants in North America, fell in Q2 on mixed results. Though organic growth in its core specialty was strong, Chefs is still getting up to speed in managing a growing proteins business and filling up newly built capacity. The result has been in-line sales growth but choppy margin performance. We think Chefs is improving management of recent acquisitions and will resume its consolidation of the finer dining restaurant distribution business.

  • Houghton Mifflin Harcourt Company is a leading publisher of educational materials and solutions for K-12 schools. Shares of Houghton Mifflin fell in Q2 due to concerns that the adoption of new English Language Arts (ELA) programs in California might be delayed. While a push-out will negatively impact bookings and revenue in the short term, in the medium and longer term, we still expect the company to benefit from this large-scale adoption, even if revenue recognition is moved into the next fiscal year.

  • Shares of Mattress Firm Holding Corp., a specialty retailer of mattresses and related products, detracted in Q2. The company lowered its earnings expectations due to a couple of one-off issues that we believe have been addressed, as well as a slowing retail environment. While we think short-to-medium-term performance may be impacted by a choppy retail environment, we retain conviction. Mattress Firm is the largest mattress retailer in the U.S., and we believe it will benefit as the domestic economy continues to strengthen.

Quarterly Attribution Analysis (for quarter ended 6/30/2016)

The Quarterly Attribution Analysis for period ending June 30, 2016 is not yet available

Back to Top

Invest In Baron Funds Today

The prospective performance of the companies discussed herein is based on our internal analysis and reflect our opinions only. We cannot promise future returns and our opinions are a reflection of our best judgement at the time of publication. Our views are not intended as recommendations or investment advise to any person and are subject to chage at any time based on market and other conditions and Baron has no obligation to update them. Investing in the stock market is always risky. Current and future portfolio holdings in the Fund are subject to risk.

Source: FactSet PA.